Skip Ribbon Commands
Skip to main content

​​​​​​​​

​​​​

Primary Diagnosis

Peripheral Vascular Disease

Study Purpose

A study to evaluate the study and effectiveness of the Ranger Paclitaxel drug coated balloon versus standard Balloon for Angioplasty of lesions in the superficial femoral and proximal popliteal arteries (SFA/PPA) in peripheral vascular disease.

Principal Investigator: Srini Potluri, MD

Trial Details

Locations: Baylor Scott & White The Heart Hospital – Plano

Sponsor: Boston Scientific

IRB Number: 016-258

Trial Status: Enrolling

Exclusions: Adults only

​Note: studies requiring extended follow-up for products that were investigational, but have become commercially available since then are not considered investigational studies.

Change in Care: ​Duplex ultrasounds will be performed at each follow up visit as well as quality of life questionnaires and a 6 minute walk

Contact Information:

Julie McCracken, CCRC
469.814.4717
Julie.McCracken@BSWHealth.org

Rachelle Winkle, RN
469.814.4183
Rachelle.Winkle@BSWHealth.org

Full Protocol Title

A 3:1 Randomized Trial Comparing the Boston Scientific RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty for the Treatment of Superficial Fermoal Arteries (SFA) and Proximal Popliteal Arteries (PPA)

Get Detailed I​nformation On Clinicaltrials.gov »​​​​​​

​​

​​

​​​​​​​​​​BAYLOR SCOTT & WHITE RESEARCH ​INSTITUTE​​